Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Mutant p53 and genomic instability in a transgenic mouse model of breast cancer.

Murphy KL, Rosen JM.

Oncogene. 2000 Feb 21;19(8):1045-51. Review. No abstract available.

PMID:
10713688
[PubMed - indexed for MEDLINE]
2.

A transgenic mouse model for mammary carcinogenesis.

Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, Rosen JM.

Oncogene. 1998 Feb 26;16(8):997-1007.

PMID:
9519874
[PubMed - indexed for MEDLINE]
Free Article
3.

Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.

Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.

Exp Mol Pathol. 2001 Jun;70(3):183-93.

PMID:
11417997
[PubMed - indexed for MEDLINE]
4.

Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.

Heinlein C, Krepulat F, Löhler J, Speidel D, Deppert W, Tolstonog GV.

Int J Cancer. 2008 Apr 15;122(8):1701-9.

PMID:
18092324
[PubMed - indexed for MEDLINE]
5.

Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.

Wijnhoven SW, Zwart E, Speksnijder EN, Beems RB, Olive KP, Tuveson DA, Jonkers J, Schaap MM, van den Berg J, Jacks T, van Steeg H, de Vries A.

Cancer Res. 2005 Sep 15;65(18):8166-73.

PMID:
16166291
[PubMed - indexed for MEDLINE]
Free Article
6.

Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.

Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.

Cancer Res. 2007 Aug 1;67(15):7212-22.

PMID:
17671189
[PubMed - indexed for MEDLINE]
Free Article
7.

Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.

Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S.

Cancer Res. 2003 Aug 1;63(15):4384-8.

PMID:
12907608
[PubMed - indexed for MEDLINE]
Free Article
8.

The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.

Moynahan ME.

Oncogene. 2002 Dec 16;21(58):8994-9007. Review.

PMID:
12483515
[PubMed - indexed for MEDLINE]
Free Article
9.

Mammary gland neoplasia: insights from transgenic mouse models.

Siegel PM, Hardy WR, Muller WJ.

Bioessays. 2000 Jun;22(6):554-63. Review.

PMID:
10842309
[PubMed - indexed for MEDLINE]
10.

The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model.

Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D, Varmus HE.

Prog Clin Biol Res. 1996;395:1-11. Review. No abstract available.

PMID:
8895979
[PubMed - indexed for MEDLINE]
11.

Mouse models for breast cancer.

Hennighausen L.

Oncogene. 2000 Feb 21;19(8):966-7. No abstract available.

PMID:
10713679
[PubMed - indexed for MEDLINE]
Free Article
12.

Mouse models and breast cancer.

Robinson A.

CMAJ. 1995 Oct 15;153(8):1123-4.

PMID:
7553521
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.

Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS, Medina D.

Oncogene. 2000 Feb 21;19(8):1052-8.

PMID:
10713689
[PubMed - indexed for MEDLINE]
Free Article
14.

Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis.

Medina D, Ullrich R, Meyn R, Wiseman R, Donehower L.

Environ Mol Mutagen. 2002;39(2-3):178-83.

PMID:
11921187
[PubMed - indexed for MEDLINE]
15.

Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.

Hadsell DL, Murphy KL, Bonnette SG, Reece N, Laucirica R, Rosen JM.

Oncogene. 2000 Feb 17;19(7):889-98.

PMID:
10702797
[PubMed - indexed for MEDLINE]
Free Article
16.

Use of p53 transgenic mice in the development of cancer models for multiple purposes.

Lubet RA, Zhang Z, Wiseman RW, You M.

Exp Lung Res. 2000 Dec;26(8):581-93. Review.

PMID:
11195457
[PubMed - indexed for MEDLINE]
17.

Diet and cancer prevention studies in p53-deficient mice.

Hursting SD, Perkins SN, Phang JM, Barrett JC.

J Nutr. 2001 Nov;131(11 Suppl):3092S-4S. Review.

PMID:
11694654
[PubMed - indexed for MEDLINE]
Free Article
18.

Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.

Ko J, Shin SM, Oh YM, Lee YS, Ryoo ZY, Lee YH, Na DS, Kim JW.

Oncogene. 2004 Mar 11;23(10):1950-3.

PMID:
14691448
[PubMed - indexed for MEDLINE]
19.

Frequent p53 and H-ras mutations in benzene- and ethylene oxide-induced mammary gland carcinomas from B6C3F1 mice.

Houle CD, Ton TV, Clayton N, Huff J, Hong HH, Sills RC.

Toxicol Pathol. 2006;34(6):752-62.

PMID:
17162533
[PubMed - indexed for MEDLINE]
Free Article
20.

Defining the steps in a multistep mouse model for mammary carcinogenesis.

Varmus HE, Godley LA, Roy S, Taylor IC, Yuschenkoff L, Shi YP, Pinkel D, Gray J, Pyle R, Aldaz CM, et al.

Cold Spring Harb Symp Quant Biol. 1994;59:491-9. Review. No abstract available.

PMID:
7587104
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk